Effects of Intravenous Fluid Restriction on Postoperative Complications: Comparison of Two Perioperative Fluid Regimens: a Randomized Assessor-blinded Multicenter Trial
Overview
Authors
Affiliations
Objective: To investigate the effect of a restricted intravenous fluid regimen versus a standard regimen on complications after colorectal resection.
Summary Background Data: Current fluid administration in major surgery causes a weight increase of 3-6 kg. Complications after colorectal surgery are reported in up to 68% of patients. Associations between postoperative weight gain and poor survival as well as fluid overload and complications have been shown.
Methods: We did a randomized observer-blinded multicenter trial. After informed consent was obtained, 172 patients were allocated to either a restricted or a standard intraoperative and postoperative intravenous fluid regimen. The restricted regimen aimed at maintaining preoperative body weight; the standard regimen resembled everyday practice. The primary outcome measures were complications; the secondary measures were death and adverse effects.
Results: The restricted intravenous fluid regimen significantly reduced postoperative complications both by intention-to-treat (33% versus 51%, P = 0.013) and per-protocol (30% versus 56%, P = 0.003) analyses. The numbers of both cardiopulmonary (7% versus 24%, P = 0.007) and tissue-healing complications (16% versus 31%, P = 0.04) were significantly reduced. No patients died in the restricted group compared with 4 deaths in the standard group (0% versus 4.7%, P = 0.12). No harmful adverse effects were observed.
Conclusion: The restricted perioperative intravenous fluid regimen aiming at unchanged body weight reduces complications after elective colorectal resection.
Son K, Tarao K, Hateruma Y, Nozaki-Taguchi N, Sato Y, Isono S Eur J Anaesthesiol Intensive Care. 2025; 2(4):e0028.
PMID: 39917070 PMC: 11783642. DOI: 10.1097/EA9.0000000000000028.
ERAS failure and major complications in elective colon surgery: Common risk factors.
Rasilainen S, Tiainen T, Pakarinen M, Bumblyte V, Scheinin T, Schramko A Surg Pract Sci. 2025; 10():100080.
PMID: 39845611 PMC: 11749998. DOI: 10.1016/j.sipas.2022.100080.
Tankel J, Chayen D, Einav S Surg Pract Sci. 2025; 12():100146.
PMID: 39845295 PMC: 11749901. DOI: 10.1016/j.sipas.2022.100146.
Lipowski P, Ostrowski A, Adamowicz J, Jasiewicz P, Kowalski F, Drewa T Cancers (Basel). 2025; 17(1.
PMID: 39796730 PMC: 11720066. DOI: 10.3390/cancers17010102.
Hussen Mostafa Adam M, Bakhit S, Ahmed M, Almahal M, Ali H, Ahmed M Cureus. 2024; 16(10):e71709.
PMID: 39552979 PMC: 11568826. DOI: 10.7759/cureus.71709.